EVH NYSE Week ended 24 Jul 2026

Weekly Investor Report

Evolent Health Inc · Healthcare · Health Information Services

Open interactive chart View report data
Latest close 4.22 USD
-27.4% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 12.4% above the Trend Line and sits at 25.9% of its 52-week range. The latest completed week returned -27.4%, after a -23.4% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 60/100 conviction, while the latest news-sentiment score is 52/100. Near-term considerations: earnings are due in 5d.

Setup score 33 out of 100
Latest Close 4.22 USD 24 Jul 2026
1W Return -27.4% latest completed week
4W Return -23.4% short-term follow-through
12W Return 12.5% quarterly tape
Trend Breadth 15.4% 8 of 52 weeks active
Volume Ratio 1.8x vs 13-week average
What is working
  • The trend backdrop is active with a 6-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
  • Volume is elevated versus the 13-week average, confirming attention.
What could go wrong
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • The share remains more than 20% below its 52-week high.
  • The latest week was a sharp negative move.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -27.4% Latest completed week; four-week move -23.4%. Indicator stack 29/72 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Volatility 60/100 conviction; expected move 49.8%. News sentiment 52/100 64 relevant articles in the latest sentiment read. Event risk 5d Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 12.4% above the Trend Line and sits at 25.9% of its 52-week range. The latest completed week returned -27.4%, after a -23.4% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.8x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.5412-week average 0.23

12-week confirmation

Trend active6/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.54Current proprietary activity-pressure read.
Buy signals2Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -23.4% over four weeks, 12.5% over 12 weeks, and -57.5% over one year. The current trend has remained active for 6 consecutive weeks.

Performance by holding period

1W-27.4%
4W-23.4%
12W12.5%
26W7.1%
52W-57.5%
Active trend streak6 weeks
Active weeks in one year8
Trend breadth15.4%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.27Latest activity-pressure read.
Pressure change-8.1%Four-week change in activity pressure.
Leadership-25.11Latest relative-leadership reading.
RS change-155.6%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 85% Model confidence 81%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength25/100Blend of value, momentum, and quality. Underlying universe rank 76; rank 1 is best.
Value72/100Relative valuation strength. Underlying universe rank 29; rank 1 is best.
Quality6/100Profitability and accounting quality. Underlying universe rank 95; rank 1 is best.
Momentum5/100Medium-term price momentum. Underlying universe rank 96; rank 1 is best.
Growth14/100Revenue and earnings growth. Underlying universe rank 87; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
0.3x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
5.0%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
14.1%
Gross profit retained from each unit of revenue.
Operating margin
-22.9%
Operating profit retained from revenue.
Free-cash-flow margin
3.5%
Free cash flow generated from revenue.
Return on invested capital
-26.7%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-21.3%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
40.0%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
1.4%
Cash dividends relative to market value.
Buyback yield
8.4%
Net share repurchases relative to market value.
Shareholder yield
9.8%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-2.6x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

EVH shows volatility options pressure with a 60/100 conviction score, put-call volume ratio of 0.05, expected move of 49.8%, and Sharemaestro trend signal active.

Conviction60/100
Expected move49.8%
Put/call volume0.05
Pressure98
Speculation43
Volatility96
Trend agreement0
Open options detail
Insider activity4 / 3

4 acquisitions and 3 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment52/100

Weighted news tone is neutral across 64 relevant articles.

9 positive · 52 neutral · 3 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings5dNext report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
Options expected move49.8%Nearest-chain priced movement where available.
52-week drawdown-59.0%Distance below the 52-week high.
13-week volatility12.4%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2612 weeks finished lower.
Best week+22.7%Week of 26 Jun.
Worst week-27.4%Week of 24 Jul.
Latest week-27.4%Week of 24 Jul.

Shape of recent returns

Strong gains8
Modest gains4
Flat weeks2
Modest losses4
Sharp losses8
Recent vol12.4%13-week weekly-return volatility.
Base vol10.4%52-week weekly-return volatility.
Up/down split23/27Count of positive and negative weeks in the 52-week window.
Average skew7.6% / -8.5%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape37/100

Trend, activity pressure, participation, and risk combine to a 37/100 tape read.

 Indicator analysis52/100

Latest 12-week confirmation: trend 6/12, activity pressure 12/12, relative leadership 0/12.

Activity pressure 0.54; No reversal markers Factors26/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 7; Small Cap Core rank 19 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Options38/100

EVH shows volatility options pressure with a 60/100 conviction score, put-call volume ratio of 0.05, expected move of 49.8%, and Sharemaestro trend signal active.

Volatility · Volatility expansion watch · Expected move 49.8% Sentiment52/100

Weighted news tone is neutral across 64 relevant articles.

Evolent Health Inc (EVH) Institutional Confidence Insiders4 / 3

4 acquisitions and 3 disposals in the latest 180-day insider tape.

 Earnings5d

Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 20264.22 USD-27.4%3.75 USD15.89 USD1.27-25.1122.9MOn
17 Jul 20265.81 USD-1.2%3.75 USD16.06 USD1.46-0.0310.1MOn
10 Jul 20265.88 USD3.0%3.69 USD16.22 USD1.40-2.209.4MOn
3 Jul 20265.71 USD3.6%3.63 USD16.38 USD1.41-6.0811.5MOn
26 Jun 20265.51 USD22.7%3.57 USD16.53 USD1.38-9.8213.8MOn
19 Jun 20264.49 USD-6.5%3.53 USD16.69 USD1.26-30.0010.2MOn
12 Jun 20264.80 USD13.7%3.52 USD16.84 USD1.29-26.0812.2MOff
5 Jun 20264.22 USD6.8%3.50 USD16.99 USD1.28-35.7013.4MOff
29 May 20263.95 USD0.0%3.52 USD17.17 USD1.32-42.368.9MOff
22 May 20263.95 USD-0.3%3.61 USD17.34 USD1.38-42.4512.0MOff
15 May 20263.96 USD-5.3%3.74 USD17.50 USD1.34-42.6715.8MOff
8 May 20264.18 USD11.5%3.86 USD17.68 USD1.09-40.5415.9MOff
1 May 20263.75 USD19.8%3.98 USD17.88 USD0.75-46.5413.2MOff
24 Apr 20263.13 USD10.2%4.13 USD18.08 USD0.31-56.1611.1MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.